Related references
Note: Only part of the references are listed.Resistance to Caspase-Independent Cell Death Requires Persistence of Intact Mitochondria
Stephen W. G. Tait et al.
DEVELOPMENTAL CELL (2010)
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Hiroyuki Niida et al.
EMBO JOURNAL (2010)
The Yin and Yang functions of the Myc oncoprotein in cancer development and as targets for therapy
Lars-Gunnar Larsson et al.
EXPERIMENTAL CELL RESEARCH (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Caspase 2-mediated tumor suppression involves survivin gene silencing
M. Guha et al.
ONCOGENE (2010)
Critical Role for Caspase-8 in Epidermal Growth Factor Signaling
Darren Finlay et al.
CANCER RESEARCH (2009)
被撤回的出版物: DNA-PKcs-PIDDosome: A Nuclear Caspase-2-Activating Complex with Role in G2/M Checkpoint Maintenance (Retracted article. See vol. 145, pg. 161, 2011)
Mingan Shi et al.
CELL (2009)
Survivin as a global target of intrinsic tumor suppression networks
Minakshi Guha et al.
CELL CYCLE (2009)
Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway
S. Inoue et al.
CELL DEATH AND DIFFERENTIATION (2009)
Gene polymorphisms, apoptotic capacity and cancer risk
Evgeny N. Imyanitov
HUMAN GENETICS (2009)
Apoptosis and cancer: mutations within caspase genes
S. Ghavami et al.
JOURNAL OF MEDICAL GENETICS (2009)
DISC-mediated activation of caspase-2 in DNA damage-induced apoptosis
M. Olsson et al.
ONCOGENE (2009)
A tumor suppressor function for caspase-2
Lien Ha Ho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Caspase-8 deficiency facilitates cellular transformation in vitro
Y. Krelin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Genetic Variants and Haplotypes of the Caspase-8 and Caspase-10 Genes Contribute to Susceptibility to Cutaneous Melanoma
Chunying Li et al.
HUMAN MUTATION (2008)
A promoter polymorphism in the CASP8 gene is not associated with cancer risk
Christopher A. Haiman et al.
NATURE GENETICS (2008)
TAp73β and DNp73β activate the expression of the pro-survival caspase-2S
Wen Hong Toh et al.
NUCLEIC ACIDS RESEARCH (2008)
Does caspase inhibition promote clonogenic tumor growth?
Ute Fischer et al.
CELL CYCLE (2007)
Apaf-1 and caspase-9 deficiency prevents apoptosis in a Bax-controlled pathway and promotes clonogenic survival during paclitaxel treatment
Katja Janssen et al.
BLOOD (2007)
Lipid rafts and nonrafts mediate tumor necrosis factor-related apoptosis-inducing ligand-induced apoptotic and nonapoptotic signals in non-small cell lung carcinoma cells
Jin H. Song et al.
CANCER RESEARCH (2007)
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers
Tong Sun et al.
NATURE GENETICS (2007)
A common coding variant in CASP8 is associated with breast cancer risk
Angela Cox et al.
NATURE GENETICS (2007)
Are promyelocytic leukaemia protein nuclear bodies a scaffold for caspase-2 programmed cell death?
Luis Sanchez-Pulido et al.
TRENDS IN BIOCHEMICAL SCIENCES (2007)
The CASBAH: a searchable database of caspase substrates
A. U. Luthi et al.
CELL DEATH AND DIFFERENTIATION (2007)
Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2
Alpna Tyagi et al.
CARCINOGENESIS (2006)
Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy
Frederique Wegran et al.
CLINICAL CANCER RESEARCH (2006)
ATM and breast cancer susceptibility
M. Ahmed et al.
ONCOGENE (2006)
Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage
H. Vakifahmetoglu et al.
ONCOGENE (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
Src kinase phosphorylates caspase-8 on Tyr380:: a novel mechanism of apoptosis suppression
Silvia Cursi et al.
EMBO JOURNAL (2006)
Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant
B Frank et al.
CARCINOGENESIS (2006)
Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis
SA Lakhani et al.
SCIENCE (2006)
Targeting XIAP for the treatment of malignancy
AD Schimmer et al.
CELL DEATH AND DIFFERENTIATION (2006)
Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis
DA Loegering et al.
CELL DEATH AND DIFFERENTIATION (2006)
Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors
D de Jong
JOURNAL OF CLINICAL ONCOLOGY (2005)
Caspase-8L expression protects CD34+hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis
A Mohr et al.
ONCOGENE (2005)
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance
Y Mizutani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Caspase-8 gene is frequently inactivated by the frameshift somatic mutation 1225_1226delTG in hepatocellular carcinomas
YH Soung et al.
ONCOGENE (2005)
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease
PM Horowitz et al.
JOURNAL OF NEUROSCIENCE (2004)
Active caspase-6 and caspase-6-cleaved Tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease
HS Guo et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die
PG Ekert et al.
JOURNAL OF CELL BIOLOGY (2004)
Expression of adhesion molecules and Ki-67 in female adnexal tumor of probable Wolffian origin (FATWO): Report of two cases and review of the literature - Case report
CC Li et al.
APMIS (2004)
Cell division and cell survival in the absence of survivin
D Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The C terminus of c-Src inhibits breast tumor cell growth by a kinase-independent mechanism
RC Ishizawar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis
A Chandele et al.
NEOPLASIA (2004)
Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer
LE Wang et al.
LUNG CANCER (2003)
Inactivating mutations of CASPASE-7 gene in human cancers
YH Soung et al.
ONCOGENE (2003)
Inactivating mutations of caspase-8 gene in colorectal carcinomas
HS Kim et al.
GASTROENTEROLOGY (2003)
The human caspase-8 promoter sustains basal activity through SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism
C Liedtke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Caspase-8 and caspase-10 activate NF-κB through RIP, NIK and IKKα kinases
Y Shikama et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
A unified model for apical caspase activation
KM Boatright et al.
MOLECULAR CELL (2003)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan et al.
ONCOGENE (2002)
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome
VS Marsden et al.
NATURE (2002)
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency
HJ Chun et al.
NATURE (2002)
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8
MR Sprick et al.
EMBO JOURNAL (2002)
Inactivating mutations of the caspase-10 gene in gastric cancer
WS Park et al.
ONCOGENE (2002)
Death effector domain-only polypeptides of caspase-8 and-10 specifically inhibit death receptor-induced cell death
Y Shikama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8.
FC Kischkel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Caspase-10 is an initiator caspase in death receptor signaling
L Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular cloning and characterization of a novel caspase-3 variant that attenuates apoptosis induced by proteasome inhibition
YH Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma
F Palmerini et al.
HUMAN PATHOLOGY (2001)
Executioner caspase-3,-6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis
EA Slee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Identification of XAF1 as an antagonist of XIAP anti-caspase activity
P Liston et al.
NATURE CELL BIOLOGY (2001)
Caspase-2 pre-mRNA alternative splicing:: Identification of an intronic element containing a decoy 3′ acceptor site
J Côté et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Immunohistochemical expression of caspase-3 as an adverse indicator of the clinical outcome in human breast cancer
L Nakopoulou et al.
PATHOBIOLOGY (2001)
Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation
TS Zheng et al.
NATURE MEDICINE (2000)
Activation of the NF-κB pathway by Caspase 8 and its homologs
PM Chaudhary et al.
ONCOGENE (2000)
Activation of NF-κB by FADD, Casper, and caspase-8
WH Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
T Teitz et al.
NATURE MEDICINE (2000)
Share Paper
